Los Angeles Capital Management LLC Morphic Holding, Inc. Transaction History

Los Angeles Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	SELL	$26.01 - $48.69 $64,322 - $120,410	-2,473 Reduced 20.58%	9,543 $359,000
Q4 2022 Feb 06, 2023	SELL	$24.14 - $30.37 $3,065 - $3,856	-127 Reduced 1.05%	12,016 $321,000
Q3 2022 Nov 02, 2022	BUY	$22.23 - $33.37 $269,938 - $405,211	12,143 New	12,143 $344,000
Q1 2022 May 06, 2022	SELL	$36.25 - $52.02 $235,045 - $337,297	-6,484 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$43.27 - $65.72 $3,072 - $4,666	-71 Reduced 1.08%	6,484 $307,000
Q2 2021 Aug 05, 2021	BUY	$45.13 - $64.99 $88,454 - $127,380	1,960 Added 42.66%	6,555 $376,000
Q1 2021 May 05, 2021	BUY	$29.77 - $84.85 $136,793 - $389,885	4,595 New	4,595 $290,000

4.7M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.